Low-dose cytarabine: chromosomal findings suggesting its cytostatic as well as differentiating effect.
Chromosome analysis of bone marrow cells of two leukemic patients treated with low-dose cytarabine were performed before initiation of therapy and after a complete remission had been achieved. Results suggest that low-dose cytarabine had a mainly cytostatic effect in one patient and a more differentiating effect in the other.